Literature DB >> 3265064

Investigational study of iodine-124 with a positron camera.

R M Lambrecht1, N Woodhouse, R Phillips, D Wolczak, A Qureshi, E D Reyes, C Graser, S Al-Yanbawi, A Al-Rabiah, W Meyer.   

Abstract

A case is presented where I-124 produced by a clinical cyclotron was used with a positron emission tomography camera for clinical usage. This represents the first report of the utilization of this modality with this radionuclide. We feel the increased spatial resolution of PET should be of value in looking at thyroid disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265064

Source DB:  PubMed          Journal:  Am J Physiol Imaging        ISSN: 0885-8276


  9 in total

1.  Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Authors:  Abass Alavi; Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

Review 2.  Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer.

Authors:  Lutz S Freudenberg; Walter Jentzen; Alexander Stahl; Andreas Bockisch; Sandra J Rosenbaum-Krumme
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

3.  Preparation and in vivo study of 124I-labelled monoclonal antibody H17E2 in a human tumour xenograft model. A prelude to positron emission tomography (PET).

Authors:  D E Snook; G Rowlinson-Busza; H L Sharma; A A Epenetos
Journal:  Br J Cancer Suppl       Date:  1990-07

4.  Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer.

Authors:  L S Freudenberg; G Antoch; W Jentzen; R Pink; J Knust; R Görges; S P Müller; A Bockisch; J F Debatin; W Brandau
Journal:  Eur Radiol       Date:  2004-06-30       Impact factor: 5.315

5.  Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report.

Authors:  L S Freudenberg; G Antoch; R Görges; J Knust; R Pink; W Jentzen; J F Debatin; W Brandau; A Bockisch; J Stattaus
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

6.  Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PET.

Authors:  Lutz S Freudenberg; Walter Jentzen; Stefan P Müller; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11-20       Impact factor: 10.057

7.  Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for localizing recurrence in patients with differentiated thyroid carcinoma.

Authors:  Jandee Lee; Kuk Young Nah; Ra Mi Kim; Yeon-Ju Oh; Young-Sil An; Joon-Kee Yoon; Gwang Il An; Tae Hyun Choi; Gi Jeong Cheon; Euy-Young Soh; Woong Youn Chung
Journal:  J Korean Med Sci       Date:  2012-08-22       Impact factor: 2.153

8.  The diagnostic value of 124I-PET in patients with differentiated thyroid cancer.

Authors:  Ha T T Phan; Pieter L Jager; Anne M J Paans; John T M Plukker; M G G Sturkenboom; W J Sluiter; Bruce H R Wolffenbuttel; Rudi A J O Dierckx; Thera P Links
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-04       Impact factor: 9.236

Review 9.  124 Iodine: a longer-life positron emitter isotope-new opportunities in molecular imaging.

Authors:  Giuseppe Lucio Cascini; Artor Niccoli Asabella; Antonio Notaristefano; Antonino Restuccia; Cristina Ferrari; Domenico Rubini; Corinna Altini; Giuseppe Rubini
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.